Cargando…

Characterization and partial purification of Candida albicans Secretory IL-12 Inhibitory Factor

BACKGROUND: We have previously shown that supernatant from Candida albicans (CA) culture contains a Secretory Interleukin (IL)-12 Inhibitory Factor (CA-SIIF), which inhibits IL-12 production by human monocytes. However, the effect of CA-SIIF on secretion of other cytokines by monocytes is unknown, a...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Mingyue, Mukherjee, Pranab K, Chandra, Jyotsna, Lattif, Ali Abdul, McCormick, Thomas S, Ghannoum, Mahmoud A
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2008
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2289826/
https://www.ncbi.nlm.nih.gov/pubmed/18282300
http://dx.doi.org/10.1186/1471-2180-8-31
_version_ 1782152343524999168
author Wang, Mingyue
Mukherjee, Pranab K
Chandra, Jyotsna
Lattif, Ali Abdul
McCormick, Thomas S
Ghannoum, Mahmoud A
author_facet Wang, Mingyue
Mukherjee, Pranab K
Chandra, Jyotsna
Lattif, Ali Abdul
McCormick, Thomas S
Ghannoum, Mahmoud A
author_sort Wang, Mingyue
collection PubMed
description BACKGROUND: We have previously shown that supernatant from Candida albicans (CA) culture contains a Secretory Interleukin (IL)-12 Inhibitory Factor (CA-SIIF), which inhibits IL-12 production by human monocytes. However, the effect of CA-SIIF on secretion of other cytokines by monocytes is unknown, and detailed characterization of this factor has not been performed. RESULTS: In this study, we demonstrate that the IL-12 inhibitory activity of CA-SIIF was serum-independent, based on the reduction of IL-12 levels in monocytes stimulated under serum-independent conditions. The minimal inhibitory dose of CA-SIIF was found to be 200 μg/ml. Investigation of CA-SIIF's effect on macrophages IL-12 production in vitro and in vivo also showed that CA-SIIF inhibited IL-12 production by murine macrophages both in vitro (from 571 ± 24 pg/ml to 387 ± 87 pg/ml; P = 0.05) and in vivo (from 262 ± 6 pg/ml to 144 ± 30 pg/ml; P < 0.05). In addition to IL-12, cytokine array analysis revealed that CA-SIIF induced differential production of other cytokines also. In this regard, reduction in levels were observed for IL-8, IL-10, IL-13, monocyte chemoattractant protein (MCP)-1, MCP-2, macrophage inflammatory protein (MIP)-1, RANTES, etc. In contrast, levels of other chemokines e.g. MCP-4, MIF and MIP-3α (P < 0.05) were increased. We also found that CA-SIIF suppressed the maturation of human monocytes to dendritic cells (CD1a expression = 13 ± 3% vs 36 ± 2% of the control; P < 0.01). Next, to identify the biochemical nature of CA-SIIF, we separated this factor into a Concanavalin A (ConA)-binding glycoprotein fraction (CA-SIIF-GP) and a non-ConA-binding protein fraction (CA-SIIF-NGP) using ConA affinity chromatography. Both fractions were then tested for this inhibitory effect on human monocyte IL-12 production. CA-SIIF-GP produced a higher inhibitory effect on IL-12 production compared to CA-SIIF-NGP and CA-SIIF crude (P < 0.01), proving that CA-SIIF is a glycoprotein in nature. CONCLUSION: CA-SIIF is a glycoprotein which exhibits serum-independent inhibition of IL-12 production from monocytes in vitro and in vivo, and also modulates differentiation of monocytes into dendritic cells. These results suggest important role for CA-SIIF in interactions of C. albicans with the host immune system.
format Text
id pubmed-2289826
institution National Center for Biotechnology Information
language English
publishDate 2008
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-22898262008-04-08 Characterization and partial purification of Candida albicans Secretory IL-12 Inhibitory Factor Wang, Mingyue Mukherjee, Pranab K Chandra, Jyotsna Lattif, Ali Abdul McCormick, Thomas S Ghannoum, Mahmoud A BMC Microbiol Research Article BACKGROUND: We have previously shown that supernatant from Candida albicans (CA) culture contains a Secretory Interleukin (IL)-12 Inhibitory Factor (CA-SIIF), which inhibits IL-12 production by human monocytes. However, the effect of CA-SIIF on secretion of other cytokines by monocytes is unknown, and detailed characterization of this factor has not been performed. RESULTS: In this study, we demonstrate that the IL-12 inhibitory activity of CA-SIIF was serum-independent, based on the reduction of IL-12 levels in monocytes stimulated under serum-independent conditions. The minimal inhibitory dose of CA-SIIF was found to be 200 μg/ml. Investigation of CA-SIIF's effect on macrophages IL-12 production in vitro and in vivo also showed that CA-SIIF inhibited IL-12 production by murine macrophages both in vitro (from 571 ± 24 pg/ml to 387 ± 87 pg/ml; P = 0.05) and in vivo (from 262 ± 6 pg/ml to 144 ± 30 pg/ml; P < 0.05). In addition to IL-12, cytokine array analysis revealed that CA-SIIF induced differential production of other cytokines also. In this regard, reduction in levels were observed for IL-8, IL-10, IL-13, monocyte chemoattractant protein (MCP)-1, MCP-2, macrophage inflammatory protein (MIP)-1, RANTES, etc. In contrast, levels of other chemokines e.g. MCP-4, MIF and MIP-3α (P < 0.05) were increased. We also found that CA-SIIF suppressed the maturation of human monocytes to dendritic cells (CD1a expression = 13 ± 3% vs 36 ± 2% of the control; P < 0.01). Next, to identify the biochemical nature of CA-SIIF, we separated this factor into a Concanavalin A (ConA)-binding glycoprotein fraction (CA-SIIF-GP) and a non-ConA-binding protein fraction (CA-SIIF-NGP) using ConA affinity chromatography. Both fractions were then tested for this inhibitory effect on human monocyte IL-12 production. CA-SIIF-GP produced a higher inhibitory effect on IL-12 production compared to CA-SIIF-NGP and CA-SIIF crude (P < 0.01), proving that CA-SIIF is a glycoprotein in nature. CONCLUSION: CA-SIIF is a glycoprotein which exhibits serum-independent inhibition of IL-12 production from monocytes in vitro and in vivo, and also modulates differentiation of monocytes into dendritic cells. These results suggest important role for CA-SIIF in interactions of C. albicans with the host immune system. BioMed Central 2008-02-19 /pmc/articles/PMC2289826/ /pubmed/18282300 http://dx.doi.org/10.1186/1471-2180-8-31 Text en Copyright © 2008 Wang et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License ( (http://creativecommons.org/licenses/by/2.0) ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Wang, Mingyue
Mukherjee, Pranab K
Chandra, Jyotsna
Lattif, Ali Abdul
McCormick, Thomas S
Ghannoum, Mahmoud A
Characterization and partial purification of Candida albicans Secretory IL-12 Inhibitory Factor
title Characterization and partial purification of Candida albicans Secretory IL-12 Inhibitory Factor
title_full Characterization and partial purification of Candida albicans Secretory IL-12 Inhibitory Factor
title_fullStr Characterization and partial purification of Candida albicans Secretory IL-12 Inhibitory Factor
title_full_unstemmed Characterization and partial purification of Candida albicans Secretory IL-12 Inhibitory Factor
title_short Characterization and partial purification of Candida albicans Secretory IL-12 Inhibitory Factor
title_sort characterization and partial purification of candida albicans secretory il-12 inhibitory factor
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2289826/
https://www.ncbi.nlm.nih.gov/pubmed/18282300
http://dx.doi.org/10.1186/1471-2180-8-31
work_keys_str_mv AT wangmingyue characterizationandpartialpurificationofcandidaalbicanssecretoryil12inhibitoryfactor
AT mukherjeepranabk characterizationandpartialpurificationofcandidaalbicanssecretoryil12inhibitoryfactor
AT chandrajyotsna characterizationandpartialpurificationofcandidaalbicanssecretoryil12inhibitoryfactor
AT lattifaliabdul characterizationandpartialpurificationofcandidaalbicanssecretoryil12inhibitoryfactor
AT mccormickthomass characterizationandpartialpurificationofcandidaalbicanssecretoryil12inhibitoryfactor
AT ghannoummahmouda characterizationandpartialpurificationofcandidaalbicanssecretoryil12inhibitoryfactor